Clinical Laboratory Medicare Audit Response: Orders, Requisitions, and Medical Necessity

A practical guide for clinical laboratories facing Medicare audits, covering treating practitioner orders, requisition and intent-to-order documentation, medical necessity, drug testing and panel risks, and how to respond to CERT, MAC, RAC, and UPIC record requests.

KNOWLEDGE CENTER

11/15/202613 min read

Clinical laboratory services are among the most frequently reviewed services in Medicare. They are high in volume, often low in individual dollar value, and dependent on documentation that the laboratory does not create and frequently does not hold. A laboratory performs a test based on an order, but the evidence that the test was reasonable and necessary lives in the ordering practitioner's medical record. When a Medicare contractor requests records, the laboratory must produce documentation that originated somewhere else, often within tight deadlines.

The stakes are significant. According to OIG's January 2026 annual data report, Medicare Part B spending on laboratory tests reached $8.4 billion in 2024, with genetic testing driving most of the growth. Medicare's Comprehensive Error Rate Testing (CERT) program consistently identifies laboratory services among the Part B services with high improper payment rates, and the most common CERT finding for labs is straightforward: insufficient documentation, including a missing order or missing documentation of the practitioner's intent to order the test. Laboratories also face reviews by Medicare Administrative Contractors (MACs), Recovery Audit Contractors (RACs), Unified Program Integrity Contractors (UPICs), and OIG, as well as enforcement actions involving drug testing, respiratory and infectious disease panels, and genetic tests.

Payment pressure adds to the challenge. Congress delayed scheduled Clinical Laboratory Fee Schedule cuts under the Protecting Access to Medicare Act (PAMA) through 2026, but cuts of up to 15 percent per year remain possible beginning in 2027, and applicable laboratories completed a new private payer data reporting period that ended July 31, 2026. With margins tight, a single denial pattern or extrapolated overpayment can have an outsized effect.

This article explains the Medicare rules that govern laboratory orders and medical necessity, what auditors examine, and how laboratories can respond to audits and reduce risk. It is educational and not legal advice. Coverage policies differ by MAC and test, so laboratories should confirm current requirements with their MAC and experienced healthcare counsel.

The Regulatory Framework

Tests Must Be Ordered by the Treating Practitioner

The foundation of Medicare laboratory coverage is 42 CFR 410.32(a). Diagnostic laboratory tests must be ordered by the physician or qualified nonphysician practitioner who is treating the beneficiary, meaning the practitioner who furnishes a consultation or treats the beneficiary for a specific medical problem and who uses the results in the management of that problem. Tests that are not ordered by the treating practitioner are not reasonable and necessary. Qualified nonphysician practitioners, such as nurse practitioners, physician assistants, and clinical nurse specialists, may order tests when they are acting within the scope of their state license and Medicare rules.

What Counts as an Order

Medicare defines an order as a communication from the treating practitioner requesting that a diagnostic test be performed. An order may be delivered in writing, electronically, or by telephone. Telephone orders must be documented by both the treating practitioner, in the patient's medical record, and the testing facility. Electronic orders through an EHR interface are common and acceptable, provided the record shows that the practitioner actually placed them.

Signatures on Requisitions

CMS does not require the ordering practitioner's signature on a requisition for clinical diagnostic laboratory tests paid under the Clinical Laboratory Fee Schedule. However, this rule does not eliminate documentation requirements. The medical record must still show that the practitioner intended the test to be performed, typically through a signed progress note, an authenticated order in the EHR, or a signed requisition. If a contractor requests documentation and the laboratory cannot produce a signed requisition, it must be able to obtain documentation of intent to order from the practitioner's records. In practice, many laboratories still obtain signatures because a signed requisition is the most efficient evidence of intent.

Documentation Responsibilities

Under 42 CFR 410.32(d), the ordering practitioner must maintain documentation of medical necessity in the beneficiary's medical record. The laboratory must maintain documentation it receives from the ordering practitioner and documentation that the information it submitted on the claim accurately reflects the information it received. When documentation is requested, the laboratory must provide it, and if the laboratory cannot obtain it from the practitioner, the claim may be denied. This shared responsibility is one of the most important dynamics in laboratory audits: the laboratory bears the financial risk for documentation it does not control.

Medical Necessity and Diagnosis Coding

Medicare generally covers laboratory tests only when they are reasonable and necessary for the diagnosis or treatment of illness or injury, with certain statutory exceptions for screening tests. Claims must include diagnosis codes that reflect the clinical reason for the test, and those codes must come from the ordering practitioner. Laboratories may not assign or infer diagnosis codes on their own, and they may not select diagnosis codes to secure payment. If the practitioner does not provide diagnostic information, the laboratory should request it before billing.

National and Local Coverage Policies

CMS and the laboratory industry negotiated a set of National Coverage Determinations for common laboratory tests, found in section 190 of the Medicare National Coverage Determinations Manual. These cover tests such as blood counts, lipid testing, thyroid testing, hemoglobin A1c, PSA, and others, and they include lists of covered diagnosis codes and frequency limitations. Local Coverage Determinations and billing articles address many other tests, including drug testing, molecular diagnostics, and vitamin D testing. Laboratories need to know which policies apply to the tests on their menus and should use the Medicare Coverage Database to track changes.

Advance Beneficiary Notices

When a laboratory expects that Medicare may deny a test as not reasonable and necessary, for example because the diagnosis does not meet NCD criteria or the test exceeds frequency limits, it may issue an Advance Beneficiary Notice of Noncoverage (ABN) before performing the test. A valid ABN shifts financial liability to the beneficiary if Medicare denies the claim. ABNs must be specific, delivered before the service, and not used routinely for every test. Blanket ABNs are invalid.

CLIA Certification

Laboratories must hold the appropriate Clinical Laboratory Improvement Amendments certificate for each test they perform, and claims for tests outside the scope of a laboratory's certificate are not payable. Auditors may verify CLIA status and test complexity, especially for physician office laboratories and new market entrants.

What Auditors Examine

The Order or Evidence of Intent to Order

Auditors first look for a valid order. They check whether an order or requisition exists for each test billed, whether it identifies the patient and the specific tests, whether it was authorized by a treating practitioner, and whether the date of the order precedes the date of service. If the requisition is unsigned, auditors look for a signed progress note or authenticated EHR order showing the practitioner's intent. Missing orders, orders for different tests than those billed, and orders dated after the specimen was collected are common findings.

The Treating Relationship

Auditors verify that the ordering practitioner was treating the beneficiary. A progress note from an encounter close in time to the order is the strongest evidence. Orders from practitioners who never saw the patient, or who saw the patient only through a brief telemarketing-driven encounter, are major red flags.

Medical Necessity in the Practitioner's Record

Auditors review the practitioner's medical record for the clinical reason for each test. They look for signs, symptoms, diagnoses, medications requiring monitoring, or other clinical facts that support the test. A diagnosis code on the requisition that is not supported anywhere in the medical record will usually not be enough.

Frequency

Many NCDs and LCDs limit how often a test may be covered. For example, some tests are covered only once per year for monitoring purposes absent a change in clinical condition. Auditors look for tests repeated more often than policies allow without documented justification.

Panels and Bundling

Auditors check whether organ or disease panels were billed only when all component tests were performed, whether component tests were unbundled when a panel code should have been used, and whether automated multichannel chemistry tests were billed correctly. They also review whether reflex tests were ordered or permitted by the practitioner and whether reflex protocols were documented.

Custom Profiles and Standing Orders

Custom panels and standing orders create particular risk. A custom profile designed by a practitioner or laboratory can result in tests performed for patients who do not need all of them. Medicare requires that each test be individually reasonable and necessary. Standing orders for recurring tests, such as monitoring in dialysis or anticoagulation, must be documented, time-limited, and tied to the patient's condition.

Date of Service

Medicare's date of service rules for laboratory tests generally use the date the specimen was collected, with exceptions, such as the 14-day rule for certain hospital outpatient specimens and special rules for molecular pathology and advanced diagnostic laboratory tests. Auditors check whether date of service and billing entity were correct, because incorrect dates can affect which entity should bill and which coverage period applies.

Coding Accuracy

Auditors verify that CPT and HCPCS codes match the test actually performed, that units are correct, and that modifiers such as QW for CLIA-waived tests and 91 for repeat tests were used appropriately.

High-Risk Laboratory Categories

Drug Testing

Urine drug testing has been a long-standing enforcement focus. Medicare distinguishes presumptive testing, which detects the possible presence of drug classes, from definitive testing, which identifies specific drugs and quantities. Definitive testing is billed with HCPCS codes G0480 through G0483 based on the number of drug classes tested. Auditors look for routine definitive testing of large numbers of drug classes without individualized orders, testing that does not reflect the patient's history and treatment, and frequency that exceeds LCD limits. Many LCDs require that definitive testing be based on the patient's specific clinical needs, that orders specify the drugs or drug classes to be tested, and that blanket orders not be used.

Respiratory and Infectious Disease Panels

Multiplex panels that test for many pathogens at once grew rapidly in recent years. OIG announced a 2026 work plan project examining Medicare payments for expanded laboratory panels testing six or more pathogens. Auditors examine whether the patient's presentation justified a broad panel rather than a targeted test.

Genetic and Molecular Tests

Genetic tests accounted for 43 percent of Part B laboratory spending in 2024 despite making up about 5 percent of volume, according to OIG. These tests carry high payment amounts and specific coverage criteria, including MolDX registration in many states, and they are frequent targets of audits and fraud cases.

Tests Ordered Through Marketing or Telehealth Arrangements

OIG has warned about schemes in which marketers or telehealth companies generate orders for laboratory tests from practitioners who do not treat the patient. Laboratories that receive orders through such arrangements face significant risk under the Anti-Kickback Statute and the False Claims Act, as well as straightforward denial of claims for lack of a treating practitioner order.

Building Audit-Ready Order and Requisition Processes

Requisition Design

A well-designed requisition supports compliance. It should identify the patient, the ordering practitioner, the date, and each test ordered. It should provide space for the practitioner to supply the diagnosis or clinical indication, without pre-printed or pre-checked diagnosis codes. It should list panels with their component tests so practitioners know what they are ordering, and it should avoid language or formatting that encourages ordering unnecessary tests. Requisitions for custom profiles should be reviewed periodically and should list each component test.

Electronic Ordering

Electronic orders through EHR interfaces reduce transcription errors and create a clear record of who placed the order and when. Laboratories should ensure that interface orders capture the ordering practitioner's identity and the diagnosis, and that the laboratory's system retains the order as received.

Intake Review

Before testing, intake staff should confirm that each order includes the required elements, that the ordering practitioner is enrolled in Medicare or validly opted to order, and that diagnosis information is present. For high-cost tests, intake should confirm that coverage criteria appear to be met and request supporting clinical documentation when needed. Orders that are incomplete should be clarified with the practitioner, and the clarification should be documented.

Ordering Practitioner Enrollment

Medicare requires that practitioners who order laboratory tests be enrolled in Medicare or have validly opted out for ordering and referring purposes. Claims for tests ordered by practitioners who are not enrolled may be denied. Laboratories should verify ordering practitioner status through Medicare enrollment data as part of intake.

Practitioner Education

Laboratories cannot control the practitioner's documentation, but they can educate. Providing ordering practices with information about coverage policies, frequency limitations, documentation requirements, and the importance of documenting the clinical reason for testing reduces the likelihood of denials. Education must not include inducements to order tests, and laboratories should avoid providing free items or services to practitioners that could implicate the Anti-Kickback Statute.

Record Retrieval Agreements

Because laboratories rely on practitioners to produce records during audits, laboratories should establish expectations with frequent ordering practices for prompt production of records in response to documentation requests. These expectations should be framed as compliance cooperation, not as conditions tied to referral volume.

Responding to a Laboratory Audit

Identify the Reviewer and the Deadline

Laboratory audits come from several sources. CERT contractors review random samples of claims to measure improper payments and generally allow a limited time to respond. MACs conduct targeted probe and educate reviews and service-specific reviews. RACs conduct postpayment reviews of approved topics. UPICs investigate potential fraud, waste, and abuse and may request records, conduct interviews, and recommend payment suspension or referral. Each reviewer has different processes and deadlines, and missing a deadline usually results in automatic denial.

Gather Complete Documentation

For each claim, assemble the order or requisition, documentation of intent to order if the requisition is unsigned, the practitioner's progress notes supporting medical necessity, the test report, evidence of CLIA certification, any ABN, and any documentation of reflex protocols or standing orders. Request records from ordering practitioners immediately, explain the deadline, and follow up persistently. Track which records have been requested and received.

Review Before Submitting

Before submitting, review each record to confirm it supports the claim. If documentation is weak, consider whether a practitioner attestation is appropriate. Medicare permits signature attestations to authenticate unsigned entries in certain circumstances, but attestations cannot add new clinical information or create documentation that did not exist at the time of service. Never alter or backdate records.

Organize the Submission

Submit records in a clear, indexed format with a cover letter that identifies each claim and the documents provided. Point reviewers to the key evidence, such as the order and the progress note documenting the clinical reason for testing.

Appeal Denials

If claims are denied, the Medicare appeals process begins with redetermination by the MAC, which must be requested within 120 days of receiving the initial determination. Subsequent levels include reconsideration by a Qualified Independent Contractor, an Administrative Law Judge hearing, Medicare Appeals Council review, and federal court review, subject to amount-in-controversy thresholds. Additional documentation obtained after the initial review can be submitted on appeal, but laboratories should submit complete evidence by reconsideration, because evidence submitted later may be excluded absent good cause.

Challenge Extrapolation

When a contractor uses statistical sampling to extrapolate an overpayment across a universe of claims, laboratories should review the sampling methodology with a qualified statistician. Errors in universe definition, sample selection, or calculation can provide grounds to challenge or reduce extrapolated amounts.

Engage Counsel When Fraud Concerns Arise

UPIC involvement, payment suspensions, subpoenas, civil investigative demands, and questions about marketing relationships signal potential fraud concerns. Laboratories should engage experienced healthcare counsel immediately in these situations.

Overpayments and Internal Audits

Internal audits allow laboratories to find problems first. A practical program samples claims regularly, weighted toward high-cost tests, high-volume ordering practitioners, and tests with frequent denials. It verifies orders, intent to order, medical necessity documentation, coding, and frequency. When internal audits identify claims that were not supported, the laboratory may have obligations under the 60-day overpayment rule in section 1128J(d) of the Social Security Act and 42 CFR 401.305 to report and return overpayments. Counsel should guide the quantification and repayment process.

Common Mistakes

• Assuming that a requisition alone proves medical necessity.

• Relying on unsigned requisitions without a way to obtain documentation of intent to order.

• Assigning diagnosis codes not provided by the ordering practitioner.

• Using requisitions with pre-printed or pre-checked diagnosis codes.

• Running custom panels or standing orders without periodic review.

• Billing definitive drug testing for large numbers of drug classes without individualized orders.

• Failing to verify ordering practitioner enrollment.

• Missing documentation request deadlines because practitioner records arrived late.

• Accepting orders from marketing or telehealth arrangements without scrutiny.

Myths About Laboratory Audits

Myth: No Signature Means No Documentation Is Needed

The signature exception applies only to the requisition. Medicare still requires documentation of intent to order and medical necessity in the medical record.

Myth: The Practitioner Is Responsible, So the Lab Is Protected

The laboratory submits the claim and receives payment. If documentation is not produced, the laboratory's claim is denied and the laboratory repays the overpayment.

Myth: Low-Dollar Tests Are Not Worth Auditing

Laboratory tests are frequently reviewed because of high volume, and extrapolation can turn small per-claim errors into large overpayments.

Myth: Following the Practitioner's Order Always Protects the Lab

Laboratories that knowingly bill for tests from questionable ordering arrangements, or that ignore obvious red flags, can face False Claims Act and Anti-Kickback Statute liability.

Questions Leadership Should Ask

• Can we produce an order or documentation of intent to order for every test we bill?

• Do our requisitions comply with Medicare rules and avoid pre-printed diagnoses?

• How quickly can we obtain medical records from ordering practitioners?

• Do we verify ordering practitioner enrollment?

• How do our drug testing and panel utilization compare with policy requirements?

• Are internal audits identifying and correcting problems?

Key Takeaways

• Medicare covers laboratory tests only when ordered by the treating practitioner who uses the results, and medical necessity must be documented in the practitioner's record.

• CMS does not require practitioner signatures on requisitions, but documentation of intent to order is still required.

• Missing orders and insufficient documentation are the most common CERT findings for laboratories.

• Drug testing, multiplex panels, genetic tests, and marketing-driven orders carry heightened risk.

• Well-designed requisitions, intake review, practitioner education, record retrieval processes, and internal audits are essential defenses.

How HealthBridge Can Help

HealthBridge helps clinical laboratories prepare for and respond to Medicare audits. Our team can review requisitions and ordering processes against Medicare requirements, audit claims for order, medical necessity, frequency, and coding compliance, design intake and record retrieval workflows, and prepare organized responses and appeals for CERT, MAC, RAC, and UPIC reviews. We also help laboratories build internal audit programs and support counsel in evaluating overpayments. If your laboratory has received a records request or wants to strengthen its documentation, please get in touch with us. We will be happy to help you with this topic.

References

• Electronic Code of Federal Regulations. 42 CFR 410.32, Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-410/subpart-B/section-410.32

• Electronic Code of Federal Regulations. 42 CFR 401.305, Requirements for reporting and returning of overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D/section-401.305

• Electronic Code of Federal Regulations. 42 CFR Part 493, Laboratory Requirements (CLIA). https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-493

• Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual, Chapter 15, Section 80, Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests. https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/bp102c15.pdf

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 16, Laboratory Services. https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c16.pdf

• Centers for Medicare & Medicaid Services. Medicare National Coverage Determinations Manual, Chapter 1, Part 3, Section 190 (Laboratory NCDs). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/ncd103c1_part3.pdf

• Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual, Chapter 3, Verifying Potential Errors and Taking Corrective Actions. https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/pim83c03.pdf

• Centers for Medicare & Medicaid Services. Comprehensive Error Rate Testing (CERT). https://www.cms.gov/cert

• Centers for Medicare & Medicaid Services. Clinical Laboratory Fee Schedule: CLFS Reporting. https://www.cms.gov/medicare/payment/fee-schedules/clinical-laboratory-fee-schedule/clfs-reporting

• First Coast Service Options (CMS contractor). CERT Insider's Guide, Part B. https://medicare.fcso.com/claims-review-programs/cert-insiders-guide-part-b-first-quarter-2025

• HHS Office of Inspector General. Reports and Publications, including the Medicare Part B lab spending data report (January 2026). https://oig.hhs.gov/reports/all/

• HHS Office of Inspector General. Work Plan: Medicare Payments to Providers for Selected Expanded Laboratory Panels. https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/medicare-payments-to-providers-for-selected-expanded-laboratory-panels/

• HHS Office of Inspector General. Special Fraud Alert: Telehealth and Telemedicine Companies (July 2022). https://oig.hhs.gov/documents/root/1045/sfa-telefraud.pdf

• U.S. Code. 42 U.S.C. 1395y(a)(1)(A), Reasonable and necessary exclusion. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1395y

• U.S. Code. 42 U.S.C. 1320a-7b(b), Anti-Kickback Statute. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1320a-7b

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources